SEC Form 4 · accession 0001209191-18-036924
ALBIREO PHARMA, INC. · ALBO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anne Klibanski
Director
Period of report
Jun 8, 2018
Accepted (ET)
Jun 11, 2018 · 4:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001322505
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $30.68 | Jun 8, 2018 | A | 11,000 | A | — | Jun 7, 2028 | Common Stock | 11,000 | 11,000 | D |
Explanation of responses
- F1This option will vest and become exercisable in equal annual installments on the first three anniversaries of the date of grant (but, in any case, to be fully vested on the day prior to the annual meeting for the third fiscal year that begins following the date of grant).